4种方案治疗社区获得性肺炎药物经济学研究

Pharmacoeconomic Evaluation on the 4 Therapeutic Regimens for Community Acquired Pneumonia

目的:研究4种治疗社区获得性肺炎方案的药物经济学效果,为临床提供最佳治疗方案。方法:采用回顾性研究方法,运用药物经济学的成本-效果分析法对4种方案进行成本与效果分析。结果:4种治疗方案效果无显著性差异(P>0.05)治疗成本分别为4 327.56、4 809.20、5 628.49、5 074.14,总有效率分别为86.20%、80.64%、90.90%、85.29%,每增加1个单位效果其增加的成本分别为50.20、86.62、276.79、820.42。结论:L1方案治疗CAP为最佳方案。

OBJECTIVE： To evaluate the pharmacoeconomic efficacy of 4 therapeutic regimens tor community acquired pneumonia so as to provide optimal therapeutic regimen for clinic. METHODS： The pharmaeoeeonomie cost - effectiveness analysis was conducted on the 4 therapeutic regimens using retrospective study. RESULTS： No signiticant difference was noted in effectiveness among the four groups （ P 〉 0.05）. The total costs fi）r the four schemes were 4 327.56 yuan, 4 809.20 yuan, 5 628.49 yuan and 5 074.14 yuan, respectively and their effective rates were 86.20%, 80.64%, 90.90% and 85.29%, respectively. The increamental costs for increase of each unit of effectiveness were 50.20 yuan, 86.62 yuan, 276.79 yuan and 820.42 yuan respectively. CONCLUSION： Therapeutic regimen L1 （CAP） was optimal tor community acquired pneumonia.